Cargando…

Covid-19 treatment-induced neuropsychiatric adverse effects

Detalles Bibliográficos
Autores principales:	García, C.A. Carrajo, Sánchez, E.B. Alonso, Huerta, D. Hernández, Gómez-Arnau, J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286227/ https://www.ncbi.nlm.nih.gov/pubmed/32636036 http://dx.doi.org/10.1016/j.genhosppsych.2020.06.001

Ejemplares similares

The impact of COVID-19 on acute psychiatric inpatient unit
por: Hernández-Huerta, Daniel, et al.
Publicado: (2020)

Neuropsychiatric manifestations in patients with long COVID in Mexico
por: Carpio-Orantes, Luis Del, et al.
Publicado: (2023)

Access barriers to electroconvulsive therapy during COVID-19 pandemic
por: Daniel, Hernández-Huerta, et al.
Publicado: (2020)

Neurological and neuropsychiatric disorders associated with COVID-19. Part II: neuropsychiatric disorders and final consideration
por: Giacalone, Martina, et al.
Publicado: (2021)

COVID-19, vaccination and neuropsychiatric sequelae: Correspondence
por: Yasri, Sora, et al.
Publicado: (2022)

Correspondence: Neuropsychiatric post-acute sequelae of COVID-19
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

COVID-19 natural herd immunity and risk of neuropsychiatric disorders
por: Losilla-Rodríguez, Beatriz, et al.
Publicado: (2020)

COVID-19 natural herd immunity and risk of neuropsychiatric disorders
por: Losilla-Rodríguez, Beatriz, et al.
Publicado: (2020)

Impact of COVID-19 pandemic on the neuropsychiatric status of Wilson’s disease
por: Lanza, Giuseppe, et al.
Publicado: (2021)

Hypotheses on the neuroimmune cross-talk between COVID-19 and neuropsychiatric disorders
por: Senra, Hugo
Publicado: (2021)

Psychiatrists as internists: Some considerations following a COVID-19 redeployment experience
por: Gómez-Arnau, Jorge, et al.
Publicado: (2021)

Psychiatrists as internists: Some considerations following a COVID-19 redeployment experience
por: Gómez-Arnau, Jorge, et al.
Publicado: (2021)

Letter to the Editor: “What Are the Long-Term Neurological and Neuropsychiatric Consequences of COVID-19?”
por: Pan, Yuehai, et al.
Publicado: (2020)

Off-label use of ivermectin for COVID-19: Are there any neuropsychiatric effects to be aware of?
por: O’Higgins, Marcelo G., et al.
Publicado: (2021)

Neuropsychiatric Lupus: The Devil is in the Detail
por: Elavarasi, Arunmozhimaran, et al.
Publicado: (2019)

A case of neurocysticercosis: Neuropsychiatric manifestations, course, and treatment
por: Gournellis, Rossetos, et al.
Publicado: (2019)

Risk of neuropsychiatric disorders in offspring of COVID-19-infected pregnant women and nutritional intervention
por: Hashimoto, Kenji
Publicado: (2020)

Neurological and neuropsychiatric disorders associated with COVID-19. Part I: overview and neurological disorders
por: Giacalone, Martina, et al.
Publicado: (2021)

Challenges with neuropsychiatric Wilson's disease
por: Åberg, Fredrik, et al.
Publicado: (2023)

Does COVID-19 increase the risk of neuropsychiatric sequelae? Evidence from a mendelian randomization approach
por: Tirozzi, Alfonsina, et al.
Publicado: (2022)

Reply to “Tachycardia, adverse effect, COVID-19 vaccine”
por: Teresa Marco García, M., et al.
Publicado: (2023)

Wilson′s disease Presenting with Neuropsychiatric Manifestations.
por: Jacob, Rajesh, et al.
Publicado: (2004)

Cotard's Syndrome as a Neuropsychiatric Sequela of COVID-19
por: Stewart, Anne Louise, et al.
Publicado: (2022)

Neuropsychiatric manifestations in a child with moyamoya disease
por: Mohapatra, Satyakam, et al.
Publicado: (2016)

Correspondence on adverse conditions of COVID-19 vaccination
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

NeuroCOVID: critical review of neuropsychiatric manifestations of SARS-CoV-2 infection
por: Oliveira, Renato, et al.
Publicado: (2020)

COVID-19, neurocognitive disorders, and civil capacity
por: Valença, Alexandre M., et al.
Publicado: (2020)

Comments on “Long term neuropsychiatric consequences in COVID-19 survivors: Cognitive impairment and inflammatory underpinnings fifteen months after discharge”
por: Tripathy, Sarvodaya, et al.
Publicado: (2023)

Neuropsychiatric complications of SLE: Raising some issues of concern
por: Pattanayak, Raman Deep, et al.
Publicado: (2011)

Neuropsychiatric profiles in patients with Alzheimer's disease and vascular dementia
por: Raina, Sunil Kumar
Publicado: (2015)

Neuropsychiatric manifestations in a child with agenesis of the corpus callosum
por: Mohapatra, Satyakam, et al.
Publicado: (2015)

Neuropsychiatric Symptoms as Early Manifestation of Progressive Supranuclear Palsy
por: Suthar, Navratan, et al.
Publicado: (2018)

Pediatric Acute-Onset Neuropsychiatric Syndrome with Capgras Syndrome
por: Sharawat, Indar Kumar, et al.
Publicado: (2021)

Neuropsychiatric outcome in attempted hanging: A case report
por: Aziz, Sadaf, et al.
Publicado: (2021)

Repurposing of Tetracyclines for COVID-19 Neurological and Neuropsychiatric Manifestations: A Valid Option to Control SARS-CoV-2-Associated Neuroinflammation?
por: Chaves Filho, Adriano José Maia, et al.
Publicado: (2021)

COVID‐19 in pregnancy: Risk of adverse neonatal outcomes
por: Mehan, Aman, et al.
Publicado: (2020)

Autoimmune Encephalitis as an Adverse Event of COVID-19 Vaccination
por: Shin, Hye-Rim, et al.
Publicado: (2022)

Tachycardia, adverse effect, COVID-19 vaccine: Correspondence
por: Sookaromdee, Pathum, et al.
Publicado: (2023)

Tachycardia, adverse effect, COVID-19 vaccine: Correspondence
por: Sookaromdee, Pathum, et al.
Publicado: (2023)

Neurological Adverse Events Associated with COVID-19 Vaccination
por: Jadali, Zohreh
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s34n81g44b1ki7rqiqmcmfu82b